Selvakumar Praveen Kumar Conjeevaram, Kabbany Mohammad Nasser, Lopez Rocio, Tozzi Giulia, Alisi Anna, Alkhouri Naim, Nobili Valerio
Department of Pediatric Gastroenterology and Hepatology, Cleveland Clinic, Cleveland, OH, USA.
Digestive Disease Institute, Cleveland Clinic, Cleveland, OH, USA.
Dig Liver Dis. 2016 Aug;48(8):909-13. doi: 10.1016/j.dld.2016.04.014. Epub 2016 Apr 29.
Within the spectrum of nonalcoholic fatty liver disease (NAFLD), recent evidence suggests that adult patients with nonalcoholic steatohepatitis (NASH) have significantly lower blood lysosomal acid lipase (LAL) activity than those with steatosis. This has not been studied in pediatric patients with NAFLD.
Investigate blood LAL activity in pediatric patients with NAFLD and assess its correlation with histological severity.
We collected data on consecutive children with biopsy-proven NAFLD including demographics, anthropometrics, and routine laboratory tests. The histological features were graded according to the NAFLD activity scoring proposed by Kleiner et al. Blood LAL activity was measured prospectively using Lalistat 2.
A total of 168 children were included for analysis. Mean age was 12.6±8.5 years, 60.1% were males and 52.4% had NASH. Children with significant fibrosis (stage 2-3, n=64) had a significantly lower LAL activity compared to those with mild fibrosis (stage 0-1, n=104). There was no significant difference in LAL activity between children with NASH compared to those without NASH.
Reduced blood LAL activity correlates with severity of liver fibrosis in children with NAFLD indicating a potential role of reduced LAL activity in the pathogenesis of NAFLD-induced fibrosis.
在非酒精性脂肪性肝病(NAFLD)范围内,最近的证据表明,患有非酒精性脂肪性肝炎(NASH)的成年患者血溶酶体酸性脂肪酶(LAL)活性明显低于患有脂肪变性的患者。尚未在患有NAFLD的儿科患者中进行此项研究。
研究患有NAFLD的儿科患者的血LAL活性,并评估其与组织学严重程度的相关性。
我们收集了经活检证实患有NAFLD的连续儿童的数据,包括人口统计学、人体测量学和常规实验室检查。根据Kleiner等人提出的NAFLD活动评分对组织学特征进行分级。使用Lalistat 2前瞻性测量血LAL活性。
共有168名儿童纳入分析。平均年龄为12.6±8.5岁,60.1%为男性,52.4%患有NASH。与轻度纤维化(0-1期,n=104)的儿童相比,显著纤维化(2-3期,n=64)的儿童LAL活性显著降低。患有NASH的儿童与未患有NASH的儿童之间的LAL活性无显著差异。
血LAL活性降低与患有NAFLD的儿童肝纤维化严重程度相关,表明LAL活性降低在NAFLD诱导的纤维化发病机制中具有潜在作用。